Determinants of Value in Coronary Artery Bypass Grafting. Issue 11 (November 2020)

• Record Type: Journal Article
• Authors: Brescia, Alexander A.; Vu, Joceline V.; He, Chang; Li, Jun; Harrington, Steven D.; Thompson, Michael P.; Norton, Edward C.; Regenbogen, Scott E.; Syrjamaki, John D.; Prager, Richard L.; Likosky, Donald S.
• Is Part Of: Circulation. Volume 13:Issue 11(2020)
• Publication Date: 2020-11
• Subjects: coronary artery bypass -- hospitalization -- inpatient -- length of stay -- pneumonia; Cardiovascular system -- Diseases -- Treatment -- Periodicals; Cardiovascular system -- Diseases -- Research -- Periodicals; Outcome assessment (Medical care) -- Periodicals; Evidence-based medicine -- Periodicals; 616.1007
• DOI: 10.1161/CIRCOUTCOMES.119.006374
• Languages: English
• ISSNs: 1941-7713

Abstract

Abstract : Background: Over 180 000 coronary artery bypass grafting (CABG) procedures are performed annually, accounting for $7 to $10 billion in episode expenditures. Assessing tradeoffs between spending and quality contributing to value during 90-day episodes has not been conducted but is essential for success in bundled reimbursement models. We, therefore, identified determinants of variability in hospital 90-day episode value for CABG. Methods: Medicare and private payor admissions for isolated CABG from 2014 to 2016 were retrospectively linked to clinical registry data for 33 nonfederal hospitals in Michigan. Hospital composite risk-adjusted complication rates (≥1 National Quality Forum-endorsed, Society of Thoracic Surgeons measure: deep sternal wound infection, renal failure, prolonged ventilation >24 hours, stroke, re-exploration, and operative mortality) and 90-day risk-adjusted, price-standardized episode payments were used to categorize hospitals by value by defining the intersection between complications and spending. Results: Among 2573 total patients, those at low- versus high-value hospitals had a higher percentage of prolonged length of stay >14 days (9.3% versus 2.4%, P =0.006), prolonged ventilation (17.6% versus 4.8%, P <0.001), and operative mortality (4.8% versus 0.6%, P =0.001). Mean total episode payments were $51 509 at low-compared with $45 526 at high-value hospitals ( P <0.001), driven by higher readmission ($3675 versus $2177, P =0.005), professional ($7462 versus $6090, P <0.001), postacute care ($7315 versus $5947, P =0.031), and index hospitalization payments ($33 474 versus $30 800, P <0.001). Among patients not experiencing a complication or 30-day readmission (1923/2573, 74.7%), low-value hospitals had higher inpatient evaluation and management payments ($1405 versus $752, P <0.001) and higher utilization of inpatient rehabilitation (7% versus 2%, P <0.001), but lower utilization of home health (66% versus 73%, P =0.016) and emergency department services (13% versus 17%, P =0.034). Conclusions: To succeed in emerging bundled reimbursement programs for CABG, hospitals and physicians should identify strategies to minimize complications while optimizing inpatient evaluation and management spending and use of inpatient rehabilitation, home health, and emergency department services. Abstract : Supplemental Digital Content is available in the text.